Jurox TMPS Antibacterial Suspension for Injection

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

TRIMETHOPRIM; SULFADIAZINE

Available from:

JUROX PTY LIMITED

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

TRIMETHOPRIM PYRIMIDINE Active 80.0 mg/ml; SULFADIAZINE SULFANYL Active 400.0 mg/ml

Units in package:

100 mL; 50 mL

Class:

VM - Veterinary Medicine

Therapeutic area:

ANTIBIOTIC & RELATED

Product summary:

Poison schedule: 4; Withholding period: MEAT (CATTLE, SHEEP, PIG, HORSE): DO NO T USE less than 28 days before slaughter for human consumption MILK (CATTLE): Milk collected from cows within 72 hour s following treatment MUST NOT BE USED f or human consumption or processing. This milk should not be fed to bobby calves . MILK (SHEEP): DO NOT USE in female sheep which are producing or may in the future produce milk or milk products for human consumption. EXPORT SLAUGHTER INTERVAL (ESI): An ESI has not been esta blished for this product. Note - observ ing the meat withholding period may not be sufficient to mitigate potential risk s to export trade. Trade advice should b e sought from Jurox Pty Limited on 1800 023 312 before using the product.; Host/pest details: CATTLE: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]; HORSE: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]; PIGS: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]; SHEEP EWE - DRY: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

JUROX TMPS ANTIBACTERIAL SUSPENSION FOR INJECTION
89892/126303
Product Name:
APVMA Approval No:
Label Name:
JUROX TMPS ANTIBACTERIAL SUSPENSION FOR INJECTION
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
400 mg/mL Sulfadiazine
80 mg/mL Trimethoprim
Claims:
Jurox TMPS Antibacterial Suspension for Injection contains 80 mg/mL
trimethoprim, a
synthetic antibacterial developed in the Wellcome Research
Laboratories, and 400 mg/mL
sulfadiazine.
Jurox TMPS Antibacterial Suspension for Injection is effective against
most Gram-positive
and Gram-negative bacteria.
The two components of Jurox TMPS Antibacterial Suspension for
Injection produce a
sequential double blockade of bacterial metabolism giving a level of
activity many times
greater than that obtained from either drug alone. Jurox TMPS
Antibacterial Suspension
for Injection may be used in the treatment of a wide range of diseases
and conditions of
bacterial origin in cattle, sheep, pigs and horses.
Jurox TMPS Antibacterial Suspension for Injection is indicated for the
systemic treatment
of:
Respiratory infections of bacterial origin including pneumonia,
bronchitis and secondary
bacterial infections following virus pneumonia.
Urogenital tract infections including cystitis, vaginitis, urethritis,
nephritis and metritis.
Alimentary tract infections including Escherichia coli infections and
salmonellosis.
Other infections, as such foul-in-the-foot, severe mastitis, bacterial
agalactia of sows,
post-operative and post-parturient uses, wound infections and
septicaemias. Jurox
TMPS Antibacterial Suspension for Injection is active in vitro against
Gram-positive and
Gram-negative organisms including Actinomyces spp., Bacillus
anthracis, Bordetella
spp., Brucella spp., Clostridium spp., Corynebacterium spp., E. coli,
Haemophilus spp.,
Klebsiella spp., Shigella spp., Staphylococci, Streptococci,
Diplococci, Enterococci and
Campylobacter spp.
Note
Erysipelothrix, Leptospira and Pseudomonas organisms ar